The downregulation of PPAR-γ expression in the liver observed in our study during the development of diet-induced obesity may be due to significant damage to liver cells, and the normalization of its level during OEA-DS therapy may be the result of a decrease in the intensity of inflammatory processes in the liver and apoptosis. Here, PPARG is linked to Obesity.